Measurable Residual <i>FLT3</i> Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
Laura W. Dillon(Institute of Cancer Research), Christopher S. Hourigan(National Heart Lung and Blood Institute), Steven M. Devine(National Marrow Donor Program), Kristin Page(Medical College of Wisconsin), Zoë C. Wong(National Institutes of Health), Devdeep Mukherjee(National Institutes of Health), Jake Higgins(University of Kentucky), Firas El Chaer(The University of Texas MD Anderson Cancer Center), Jeffrey E. Miller(MesoScribe Technologies (United States)), Jesse J. Salk(University of Washington), Georgia Andrew(National Institutes of Health), Gege Gui(Johns Hopkins University), Wael Saber(Medical College of Wisconsin), Stephen R. Spellman(National Marrow Donor Program), Partow Kebriaei(The University of Texas MD Anderson Cancer Center), Antonio Martin Jimenez-Jimenez(Sylvester Comprehensive Cancer Center), Mark R. Litzow(Mayo Clinic in Arizona), Jeffery J. Auletta(Nationwide Children's Hospital), Ying Huang(MesoScribe Technologies (United States)), Matt Holman(MesoScribe Technologies (United States)), Marcos J.G. De Lima(The Ohio State University), Jason Gerhold(MesoScribe Technologies (United States)), Scott L. Zeger(Johns Hopkins University), J. D'Angelo(MesoScribe Technologies (United States)), Niveditha Ravindra(National Institutes of Health)
Cited by 58
Related Papers
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k